🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this 3 part study are; Part 1: to investigate the pharmacoki...
Status
Completed
Location
PRA Health Sciences
Start Date
2018-08-28
Trial ID
NCT03649997
Treatments Being Tested
This is an open-label, randomized, three-period crossover study evaluating ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07300020
The main purpose of this study is to assess the bioequivalence of ocrelizum...
Status
Active Not Recruiting
Location
Profound Research, LLC
Start Date
2025-11-13
Trial ID
NCT07074886
Treatments Being Tested
The purpose of this study is to understand changes in brain chemical signal...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2002-10
Trial ID
NCT00178828
Treatments Being Tested
This is the first study to evaluate the safety and clinical activity of the...
Status
Completed
Location
UCSF Benioff Children's Hospital, Oakland
Start Date
2017-06-06
Trial ID
NCT03139331
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Status
Completed
Location
Baylor Research Institute
Start Date
2009-03-01
Trial ID
NCT00851877
Treatments Being Tested
This study will evaluate the drug behavior and safety of a single dose of t...
Status
Completed
Location
Glendale Adventist Medical Center
Start Date
2014-04-11
Trial ID
NCT02084875
Treatments Being Tested
The purpose of this study is to evaluate safety and immunogenicity of a sin...
Status
Completed
Location
G. D'Annunzio University
Start Date
2005-06
Trial ID
NCT00316628
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics and safety of ...
Status
Completed
Location
H Plus Yangji Hospital
Start Date
2021-10-05
Trial ID
NCT05023031
Treatments Being Tested
A randomized, placebo-controlled, dose-escalation, crossover study....
Status
Completed
Location
Seoul National University Hospital
Start Date
2019-12-16
Trial ID
NCT05345912
Treatments Being Tested